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Aims: Gastrointestinal complaints are common in diabetes mellitus. However, its association to peripheral
sensorimotor and autonomic neuropathies is not well investigated. The aim was to assess skin, muscle, bone
and visceral sensitivity in diabetes patients with sensorimotor neuropathy, and correlate these with
gastrointestinal symptoms and degree of cardiac autonomic neuropathy.
Methods: Twenty patients with sensorimotor neuropathy (65% type 2 diabetes, aged 58.3 ± 12.0 years,
diabetes duration 15.8 ± 10.0 years) and 16 healthy controls were recruited. Cutaneous sensitivity to
von Frey filaments, mechanical allodynia, muscle/bone/rectosigmoid sensitivities, and heart rate variability
were examined. Gastrointestinal symptom scores (PAGI-SYM) and health-related quality of life (SF-36) were
also recorded.
Results: Patients displayed hypesthesia to von Frey filaments (p = 0.028), but no difference to muscle and
bone pain sensitivities. Also, patients were hyposensitive to multimodal rectal stimulations (all p b 0.05),
although they suffered more gastrointestinal complaints. Heart rate variability was reduced in the patient
cohort. Rectal mechanical and cutaneous sensitivities correlated (p b 0.001), and both were associated with
heart rate variability as well as PAGI-SYM and SF-36 scores (p b 0.01).
Conclusions: In diabetic sensorimotor neuropathy there is substantial evidence of concomitant cutaneous,
cardiac and visceral autonomic neuropathies. The neuropathy may reduce quality of life and explain the
higher prevalence of gastrointestinal complaints.
© 2014 Elsevier Inc.Open access under CC BY-NC-ND license. 1. Introduction
Diabetes mellitus (DM) is one of the most common causes of
chronic morbidity world-wide, leading to late complications in a greatved funding from theNorwegian
nd the European Community’s
ant agreement no. 223630.
e are no dualities of interest
aukeland University Hospital,
(E. Søfteland).
C-ND license. number of patients. Neuropathy, a condition in which the nerve signal
quality and velocity is reduced, is one of the most prevalent late
complications, affecting around 50 % of all diabetes patients (Tesfaye
et al., 2010). In its typical form, diabetic sensorimotor polyneuropathy
(DSPN) affects both large myelinated as well as small unmyelinated
nerve fibers. The condition is most commonly investigated through
examination of large fiber conduction velocity, leaving the small nerve
fibers unassessed (Dyck et al., 2011). However, measuring small fiber
patency may be even more relevant, but is more complicated with
various tests being advocated, such as corneal confocal microscopy,
quantitative sensory testing, laser Doppler imager flare, sudomotor
tests and intraepidermal nerve fiber density (Papanas & Ziegler, 2011;
Rage et al., 2011; Tesfaye et al., 2010; Vas, Green, & Rayman, 2012).
371E. Søfteland et al. / Journal of Diabetes and Its Complications 28 (2014) 370–377The entire gastrointestinal (GI) tract may also be affected in DM,
producing awide variety of symptoms.Manypatients are undiagnosed
and under-treated, because the GI tract has not traditionally been
associatedwithDMand its complications. Complaints such as bloating,
vomiting, pain, constipation and diarrhea are more prevalent in DM
compared to the general population, affecting 30–70% (Bytzer et al.,
2001; Ko, Chan, Chan, Tsang, & Cockram, 1999; Ricci et al., 2000).
Although the visceral complications in diabetes were already known
and described in a review by Rundles in 1945, the pathophysiological
mechanisms are still not clear (Rundles, 1945). Visceral autonomic and
enteric neuropathies, autoantibodies, changed intestinal microbiota,
direct glucose effects, increased stiffness of the GI wall, exocrine
pancreatic insufficiency, disordered gut–brain axis and humoral
alterations are among the involved mechanisms, and likely etiology
ismultifactorial (Brock et al., 2012; Bures et al., 2010;Darwiche, Almer,
Bjorgell, Cederholm, & Nilsson, 2001; Frokjaer et al., 2007; Granberg,
Ejskjaer, Peakman, & Sundkvist, 2005; Rayner, Samsom, Jones, &
Horowitz, 2001). Recent studies have demonstrated esophageal
hyposensitivity and altered central sensory processing in DM patients
with symptoms of gastroparesis (Brock et al., 2012). In line with this,
microstructural changes in the brain areas involved in visceral sensory
processing have been discovered, using magnetic resonance diffusion
tensor imaging (Frokjaer et al., 2013).
To date, no study has examined the relationship between
sensitivities in different tissues (skin, mucles, bone and viscera) in
patients with DSPN. Using the rectosigmoideum as a visceral proxy,
the aims of the present study were 1) to investigate somatic and
visceral sensitivity in patients with DSPN using a multimodal,
multitissue approach, 2) to characterize the association between
sensorimotor (somatic), visceral and cardiac autonomic sensitivities




Twenty patients with DM and sensorimotor neuropathy (average
age 58.3 years, 10 women,) were recruited from Haukeland Univer-
sity Hospital, Bergen, Norway (Department of Internal Medicine and
Section for Clinical Neurophysiology) and Saint George Hospital,
Székesfehérvár, Hungary. The presence of sensorimotor neuropathy
was defined according to the respective national guidelines, in line
with the 2005 statement by the American Diabetes Association
(Boulton et al., 2005). Sixteen healthy controls, matched for age and
gender (9 women, age 62.6 years) were recruited through newspaper







Age (years) 58.3 (± 12.0) 62.6 (± 10.5) NS
Gender (male/female) 10/10 7/9 NS
Body mass index BMI (kg/m2) 28.0 (± 3.62) 25.8 (± 3.38) NS
Diabetes duration (years) 15.8 (± 10.0) – –
Diabetes type (1/2) 35/65 % – –
HbA1c (%) 8.0 (± 1.0) – –
Retinopathy (%) 28 – –
Creatinine level (μmol/l)a 68.5 (± 15.8) 71.3 (± 13.2) NS
Smoking status (present/past/never) 2/8/9 2/10/4 NS
Hypertension (%) 81 19 0.001
Beta-blocker (%) 27 0 0.04
ACEI/angiotensin receptor blocker (%) 71 13 0.004
Statin use (%) 67 19 0.02
Metformin (%) 57 – –
Data are means (± SD) unless otherwise indicated. NS = not significant.
a All estimated glomerular filtration rates N 60 ml/min/1.73 m2.Table 1. Presence of retinopathy was based on anamnestic informa-
tion and patient journals.
The exclusion criteria were clinical conditions that might influence
the visceral sensitivity (i.e. inflammatory bowel disorder, previous
abdominal surgery, peptic ulcers), as well as neurological or
psychiatric disorders that might interfere with study results.
Medications known to affect GI motility or pain perception were
ceased at least 24 h prior to experimental testing. Oral and written
informed consents were obtained from all subjects, and the study
was approved by the local ethic committees at Haukeland and
St. George Hospitals.
2.2. Questionnaires
Subjects were asked to rate their gastrointestinal symptoms
during the preceding two weeks using the validated Patient
Assessment of Upper Gastrointestinal Disorder Severity Symptom
Index (PAGI-SYM) (Revicki et al., 2004). Symptoms were graded from
0 (no symptoms) to 5 (very severe symptoms), and the scores were
combined into six subscales; postprandial fullness/early satiety,
nausea/vomiting, bloating, upper and lower abdominal pain and
heartburn/regurgitation. The Short Form Health Survey (SF-36) was
applied to assess quality of life. Eight subscales and two summary
scales were calculated according to previously validated methods
(Garratt, Schmidt, Mackintosh, & Fitzpatrick, 2002).
2.3. Experimental protocol
Sensory testing was performed following an overnight fast and
after administration of a suppository to empty the rectum (dioctyl
sodium sulfosuccinate and sorbitol, Klyx©, Ferring AS, Copenhagen,
Denmark). All subjects underwent a hyperinsulinemic clamp proce-
dure, aiming at a blood glucose level of 6.0 mmol/L in order to limit
any effect of hyperglycemia and hyperinsulinemia on the visceral
sensitivity (Frokjaer, Softeland, Graversen, Dimcevski, & Drewes,
2010; Softeland et al., 2011). The subjectswere instructed in the use of
a 0–10 electronic Visual Analogue Scale (VAS), which was later
employed during the sensory testing. The use of VAS was facilitated
through anchor words, where 0 = no perception; 3 = vague per-
ception of moderate sensation; 5 = pain detection threshold; 7 =
moderate pain and 10 = worst perceivable pain. VAS was recorded
continuously during testing. The scale has been widely used in
somatic and visceral sensory experiments, and has been described in
detail previously (Brock et al., 2008; Dimcevski et al., 2007). Somatic
and visceral sensory testing was completed in two hours on average,
with another two hours needed for clamp preparation, blood glucose
adjustment and the rectal suppositories. The order of testing was as
indicated by the subsections below.
2.3.1. Somatic sensory testing
2.3.1.1. First sensation of von Frey filaments. Quantitative sensation of
light touchwasmeasured by use of Optihair von Frey-like filaments of
increasing diameter at the base of the dorsum of the first toe,
dominant foot (Marstock Nervtest, Schriesheim, Germany). The
weight corresponding to first sensation was determined (Rolke
et al., 2006).
2.3.1.2. Brush-induced allodynia. Dynamic allodynia was tested on a
2 × 6 cm area on the dorsum of the dominant foot. The SENSELab
Brush-06 (Somedic AB, Hörby, Sweden) was used, aiming at a swipe
speed of 4 cm/s (Samuelsson, Leffler, Johansson, & Hansson, 2007).
VAS score following the first and the sixth consecutive swipes
were assessed.
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giving 10 pin-pricks at a rate of 1/s using the 26 g von Frey
monofilament within a 1 × 1 cm area just proximal of the first toe
of the dominant foot. VAS was assessed at first and last prick. In case
the patient was unable to feel the 26 g monofilament, the filament
size corresponding to VAS 1 was used (Rolke et al., 2006).2.3.1.4. Muscle pressure algometry. Pressure sensitivity on the
dominant lateral side of the anterior tibial muscle was examined
by use of a handheld electronic pressure algometer (Somedic AB,
Hörby, Sweden). The probe had a surface area of 1 cm2. Pressure
increased by 30 kPa/s until VAS 7 was reached. This examination was
performed three times, and the mean pressure was calculated (Staahl
et al., 2007).2.3.1.5. Bone pressure algometry. Pressure was applied on the flat side
of the dominant tibial bone, approx. 15 cm distal of the patella. The
same pressure algometer was used, however the probe had a smaller
surface area of 0.031 cm2. Pressure increased with 970 kPa/s, and the
mean of three test runs was calculated (Andresen, Pfeiffer-Jensen,
Brock, Drewes, & Arendt-Nielsen, 2013).2.4. Visceral sensory testing
The rectal sensitivities to thermal, mechanical and electrical
stimulations were examined by use of a multimodal probe (Ditens
A/S, Aalborg, Denmark). The probe, which has an outer diameter of
6.2 mm, was positioned in the rectosigmoidum through a small
anoscope, as described in greater detail previously (Brock et al., 2008).Table 2
Results of the cardiac autonomic tests.
Heart rate variability parameter Patients Healthy controls p-value
HRV at rest Mean HR 76.1 (±9.4) 61.3 (±9.0) b0.001
SDNN 20.4 (17–34) 43.2 (29–66) 0.009
RMS-SD 21.9 (14–25) 31.2 (19–65) 0.0562.4.1. Visceral thermal stimulation
Heat sensitivity was examined by circulating heated water
through a rectal bag pre-filled with 60 ml water, using a volume-
controlled pump (Ole Dich Instrument Makers, Hvidovre, Denmark).
The balloon temperature increased gradually from 37 °C to a
maximum of 60 °C. The stimulation was halted when reaching a
sensation of VAS 7, and to minimize the unpleasantness the warm
water was immediately evacuated. The balloon temperature corre-
sponding to VAS 7 was recorded (Brock et al., 2008).TP 130.5 (80–358) 394.0 (249–949) 0.025
LF Norm 44.3 (21–76) 71.2 (57–87) 0.036
HF Norm 55.7 (24–79) 28.8 (13–43) 0.036
LF/HF 0.80 (0.27–3.3) 2.47 (1.3–6.8) 0.036
HRV during deep
respiration
SD of HR 3.25 (±2.0) 5.63 (±2.8) 0.012
Mean variance
of HR
7.11 (±5.6) 13.3 (±8.1) 0.020
E/I Ratio 1.08 (1.03–1.17) 1.19 (1.12–1.39) 0.017
HRV when
standing up
30:15 Ratio 1.07 (1.03–1.16) 1.39 (1.25–1.44) b0.001
Time HR max 14.8 (9.3–24.5) 5.75 (3.5–11.5) 0.004
Time HR min 22.3 (16.3–33.3) 17.8 (11.5–20.0) 0.072.4.2. Visceral mechanical stimulation
Mechanical volume sensitivity was examined by distending the
rectal bag, infusing 37 °C water through the pump. In order to ensure
proper accommodation towards the pressure sensation, three
preconditioning balloon distensions until a sensation of VAS 5 were
performed. Then, sensitivity to mechanical stimulation was examined
by recording the bag volume necessary to induce the sensation of VAS
7 (Brock et al., 2008).Data are presented as means (± SD) or median (IQ-range).
Parameters HRV at rest: Time domain; Mean HR = mean heart rate during rest,
SDNN = standard deviation from the mean heartbeat interval value (net effect of the
autonomic regulation), RMS-SD = root mean square of the standard deviation
(activity level of the parasympathetic regulation). Frequency domain; TP = total
power (power spectrum of RR intervals throughout the frequency ranges − net
autonomic function), LF Norm = low frequency activity (represents sympathetic
tone), HF Norm = high frequency activity (represents parasympathetic tone), LF/HF =
low/high frequency ratio (balance between sympathetic and parasympathetic activity).
Parameters HRV during deep respiration: SD of HR = standard deviation of the HR
value, mean variance of HR = mean variation of heart rate among all breathing cycles,
E/I-ratio = mean ratio between the longest and shortest RR-interval during deep
respiration (all are measures of baroreflex sensitivity and capacity — predominantly
parasympathetic tests).
Parameters HRV when standing up: 30:15 Ratio = ratio between maximum HR within
the first 15 s after standing up and minimum HR within the first 30 s after standing up
(predominantly parasympathetic test), time HR max (combined sympathetic and
parasympathetic effect), time HR min (predominantly parasympathetic test).2.4.3. Visceral electrical stimulation
The probe contained two stainless steel electrodes at the tip, and
mucosal contact was ensured by measuring the impedance. Subjects
in which it was not possible to achieve impedance below 5 kΩ were
discarded from the subsequent statistical analysis. The electrical
stimulation was given as a single 2 ms square pulse, starting at 1 mA
and increasing gradually in 1–3 mA steps using a voltage-controlled
current source stimulator (IES 230, JNI Biomedical ApS, Klarup,
Denmark). Due to safety considerations, maximum current intensity
was 50 mA. Intermittent sham stimuli were given in order to ensure
blinding to the ascending stimulation intensity as well as to avoid the
effect of accommodation and expectation. The current intensities
needed to induce a sensation of VAS 1, 3, 5 and 7 were assessed.2.5. Cardiac autonomic nervous system tests
All subjects were investigated on a separate occasion and in a
fasting state. The autonomic nervous system patency was assessed
through three test of heart rate variability (HRV) using the Heart
Rhythm Scanner PE (Biocom Technologies, Poulsbo, WA, USA). The
system investigates both time- and frequency domain measures of
the HRV and its use has been described and validated elsewhere
(1996; Zhang, 2007). Recordings were reviewed offline by the first
author. Minor problems, such as mis-sensed beats were corrected.
Subjects in which there were multiple ectopic beats or frank
arrhythmias were excluded from further HRV analysis. The following
tests were performed:
2.5.1. HRV during at 5-min rest
Subjects were instructed to rest in a semi-reclined position,
and the surroundings were designed to avoid emotional arousal.
See Table 2 for a complete list of parameters that were included in
further analysis.
2.5.2. HRV upon deep respiration
Deep respiration triggers the baroreflex, which leads to heart rate
fluctuations, primarily through a parasympathetic route. Subjectswere
instructed to breathe deeply with a rate of six breaths perminute, for a
total recording period of one minute. The examination was repeated if
necessary, to ensure deep and regular respiratory movements.
2.5.3. HRV as well as 30:15 ratio when standing up
This ratio is thought to predominately represent the capacity of
the parasympathetic nervous system. Subjects rested in a semi-
reclined position for five minutes and were then instructed to stand




























ANOVA:  F = 14, p < 0.001
Fig. 1. The rectal sensitivity to thermal stimulation. ANOVA analysis included all VAS
levels, and the post-hoc results of the individual VAS levels are provided. Patients
showed overall hyposensitivity to heat. Y-axis describes the baseline-corrected
temperature increase needed to induce the sensation of corresponding VAS scores



























ANOVA:  F = 14, p < 0.001
Fig. 2. The rectal sensitivity tomechanical stimulation. ANOVA analysis included all VAS
levels, and the post-hoc results of the individual VAS levels are provided. Patients
showed overall hyposensitivity. Y-axis describes the balloon volume needed to induce
the corresponding VAS scores. *p ≤ 0.05. Error bars represent SD.
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after standing up and minimum heart rate within the first 30 s after
standing up.
2.6. Statistics
Normally distributed results are presented as mean (±SD)
whereas non-normally distributed results as median (interquartile
(IQ) range). One-way analysis of variance (ANOVA) was used to
compare the two groups in terms of skin sensitivity, cardiac
autonomic parameters and the questionnaires. Two-way ANOVA
was used when comparing overall and VAS-level specific visceral,
muscle and bone sensitivities. Pearson correlation analysis was
performed in normally distributed data, and Spearman Rank
correlation otherwise. Statistical significance was defined as
p ≤ 0.05. SigmaPlot 11 (Systat Software Inc., San Jose, CA, USA) was
used for statistical analysis.
3. Results
All subjects underwent the hyperinsulinemic clamp without any
adverse events. One patient did not complete any visceral stimulation
due to strong discomfort upon insertion of the anoscope.
3.1. First sensation of von Frey filaments
Patients showed hypesthesia compared to controls, needing
significantly thicker von Frey filaments in order to reach first
sensation. Median thickness in patients 3.0 g (0.8–12.5), controls
1.0 g (0.4–1.4), p = 0.028.
3.2. Brush-induced allodynia
There was a trend towards decreased sensitivity but no change to
allodynia in patients. Least square mean of VAS score at the 1st
swipe in patients was 1.55 (±0.9) vs. 2.03 (±0.6) in controls, p =
0.07. At the 6th swipe: patients 1.7 (±1.3) vs. controls 1.97 (±0.50),
p = 0.2.
3.3. Temporal summation
Threepatients didnot feel the standard26 gmonofilament andwere
tested using themonofilament size representing the sensation of VAS 1.
Another patient did not feel any of the available filament sizes. Overall,
in both patients and controls there was a dynamic pattern through the
repetitive stimuli showing significant temporal summation, as the first
prickmeanVAS scorewas2.2 (±1.1)whereas the tenth prickmeanVAS
scorewas 3.2 (±1.4), F = 9.1, p = 0.004. However, sub-group analysis
did not reveal different summation in patients compared to controls
(all p N 0.05).
3.4. Muscle and bone algometry
No differences between the patients and controls could be
detected in terms of muscle and bone pain sensitivity. Mean pressure
inducing amuscle sensation of VAS 7was 415 (±232) kPa in patients,
and 481 (±220) kPa in controls, p = 0.13. Corresponding bone
pressures were 138 (±107) kPa in patients, and 150 (±50) kPa in
controls, p = 0.50.
3.4.1. Visceral thermal stimulation
Fig. 1 illustrates the sensitivities to rectal thermal stimulations in
the two groups. Patients were hyposensitive compared to controls,
with an overall baseline corrected temperature increase of 18.0
(±9.1) °C vs. 13.3 (±7.0) °C in controls (F = 14, p b 0.001)..
3.4.2. Visceral mechanical stimulation
Fig. 2 depicts the sensitivities to rectal mechanical stimulation.
Patients were hyposensitive; overall balloon volume 204 (±125) ml
in patients vs. 147 (±87.7) ml in controls, F = 14, p b 0.001.
3.4.3. Visceral electrical stimulation
Sensitivities to rectal electrical stimulation are shown in Fig. 3. Two
patients were unable to complete the examination due to discomfort,
whereas four healthy controls were excluded due to lack of mucosal
contact. Patients were hyposensitive; overall current intensity was
40.3 (±11.3) mA vs. 34.9 (±11.4) mA in healthy controls, F = 7,
p = 0.009.
3.5. Autonomic nervous system tests
Heart rate variability tests were completed in all subjects except
five patients; one was lost to follow-up, two were excluded due to
atrial fibrillation and two due to frequent ectopic heart beats. Patients
demonstrated significant changes in 12 out of 13 parameters, affecting
both sympathetic and parasympathetic fibers of the autonomic
nervous system (Table 2).
3.6. Questionnaires
3.6.1. SF-36
The SF-36 was completed in 12 patients and 16 controls. Patients’





















Sensitivity to electrical stimulation
Controls
Diabetes
ANOVA:  F = 7, p = 0.008
Fig. 3. The rectal sensitivity to electrical stimulation. ANOVA analysis included all VAS
levels, and the post-hoc results of the individual VAS levels are provided. Patients
showed overall hyposensitivity. Y-axis describes the current intensity needed to induce
the corresponding VAS scores. The current increment blunts as the VAS increases, as a
growing number of subjects reached the pre-defined maximal current intensity
(50 mA). Error bars represent SD.
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physical health as poorer than in the aged matched control group
(physical functioning, role limitation due to physical health, bodily
pain, general health and vitality, all p b 0.001). Mental health and
social functioning were also reduced, although the changes were less
pronounced, p b 0.05. Looking at the summary scores, there was a
highly significant reduction in the physical summary score; patients
median score 37 (IQ-range 24–46) vs. healthy controls 55 (50–57),
p b 0.001. However, there was no difference between the two groups
in the mental summary score, p N 0.05.
3.6.2. PAGI-SYM
The PAGI-SYM questionnaire was completed in 10 patients and 16
controls. The two groups differed in terms of total score (p = 0.008)
as well as four out of the six subscales; postprandial fullness (p =
0.017), upper abdominal pain (p = 0.035), lower abdominal pain
(p = 0.004) and heartburn/regurgitation (p = 0.004). No difference
could be found with respect to nausea/vomiting (p = 0.146) or
bloating (p = 0.076).
3.7. Correlations
3.7.1. Correlations between visceral and monofilament skin sensitivity
The size of von Frey filament upon first sensation was positively
associated with the overall rectal mechanical sensitivity (r = 0.45,
























Fig. 4. Short Form-36 scores. The following subscales were calculated: physical
functioning (PF), role limitations due to physical health (RP), bodily pain (BP), general
health (GH), energy fatigue/vitality (VT), social functioning (SF), role limitations due to
emotional problems (RE) and mental health (MH). Two summary scores were
established, the physical (PCS) and mental (MCS) component summaries. *p ≤ 0.05,
**p ≤ 0.01, ***p ≤ 0.001, ns = not significant.mechanical hyposensitivity. There were no such associations to rectal
electrical or thermal sensitivities.
3.7.2. Correlations between types of visceral stimulation
Sensitivity to rectal electrical stimulation correlated positively
with mechanical sensitivity (r = 0.52, p = 0.006). No other signifi-
cant associations between types of visceral stimulation could be found
(all p N 0.08).
3.7.3. Correlations between visceral sensitivity and heart rate variability
As shown in Fig. 5A, the rectal mechanical sensitivity correlated
with SDNN at rest (r = −0.52, p b 0.01). Furthermore there were
several less strong associations; rectal mechanical sensitivity and total
spectral power (r = −0.40, p = 0.04), E/I-ratio (r = −0.36, p =
0.05), 30:15 ratiowhen standing up (r = −0.38, p = 0.04). Similarly,
we noted associations between rectal electrical sensitivity and SDNN
at rest (r = −0.42 and p = 0.05), and rectal thermal sensitivity and
the 30:15 ratio when standing up (r = −0.37, p = 0.05). No other
significant correlations were found. In summary, the more impaired
HRV, the more visceral hyposensitivity.
3.7.4. Correlations between SF-36, visceral and cardiac autonomic
nervous function
Physical summary score of the SF-36 (PSC) correlated with the
mechanical sensitivity of the rectum (r = −0.49, p = 0.009), and
with several key components of the HRV, such as SDNN at rest (r =
0.59, p = 0.003), E/I-ratio (r = 0.60, p = 0.001) and 30:15 ratio
(r = 0.557, p = 0.005), see Fig. 5B–C. Overall, subjects with poor
physical health had impaired HRV and rectal hyposensitivity.
3.7.5. Correlations between PAGI-SYM, visceral and cardiac autonomic
nervous function
The 30:15-ratio upon standing up correlated with both upper
abdominal pain (r = −0.63, p = 0.002) and lower abdominal pain
(r = −0.53, p = 0.009) scores. Additionally, there were several
weaker associations; between E/I-ratio and upper abdominal pain
scores (r = −0.48, p = 0.02), between SDNN at rest and both upper
and lower abdominal pain scores (both r = −0.47, p = 0.02), and
between rectal electrical sensitivity and upper abdominal pain
(r = 0.46, p = 0.03).
4. Discussion
The present study showed that diabetes patients with sensorimo-
tor neuropathy demonstrated cutaneous hypesthesia, clear signs of
diffuse autonomic impairment affecting both the visceral sensory
system (rectal hyposensitivity to multimodal stimulations) as well as
cardiac autonomic nervous function expressed as reduced heart rate
variability. Also, the patients had increased prevalence of gastroin-
testinal complaints and reduced quality of life. Furthermore, there
were meaningful associations between skin hypesthesia, visceral
hyposensitivity, degree of cardiac autonomic neuropathy, reduced
physical wellbeing and abdominal pain scores.
4.1. Methodological considerations
Patients were recruited on the basis of clinical suspicion of DSPN
(i.e. symptoms and pathological 10 g monofilament test), 10 out of 20
were confirmed by nerve conduction studies. As such, not all cases
fulfilled the Toronto criteria, which were formulated after the study
protocol was written (Tesfaye et al., 2010). However, the patient
group showed a clearly reduced sensitivity to von Frey filament test,
confirming peripheral hyposensitivity. Furthermore, one can specu-
late that any visceral hyposensitivity found in this study most likely
would be more pronounced if all patients were selected based on
stricter definitions of peripheral neuropathy. The study cohort
Fig. 5. A: A negative correlation could be found between SDNN at rest and rectal mechanical sensitivity, indicating that subjects with reduced SDNN (i.e. decreased heart rate
variability) were hyposensitive to mechanical stimulation (volume) in the rectum. B: A negative correlation could be found between the SF-36 physical component summary score
and rectum mechanical sensitivity, indicating that subjects with reduced PCS (i.e. poorer perceived physical health) were hyposensitive to mechanical (volume) stimulation in the
rectum. C: A positive correlation could be found between the SF-36 physical component summary score and heart rate variability upon deep respiration (baroreflex sensitivity),
indicating that subjects with reduced PCS (i.e. poorer perceived physical health) had reduced baroreflex patency.
375E. Søfteland et al. / Journal of Diabetes and Its Complications 28 (2014) 370–377consisted of both type 1 and type 2 diabetes (35:65 ratio). Although
the two conditions differ in central pathophysiological aspects, they
share the presence of microvascular complications, which are
regarded as diabetes specific. In our study, the type 2 DM patients
were somewhat older than type 1, and had shorter disease duration.
Still, sub-group analyses detected no significant differences in terms
of cutaneous, muscle, bone and visceral sensitivities between the two
groups. Also, the cardiac autonomic tests and questionnaires yielded
scores that did not differ significantly. Thus, we consider our results to
be applicable in DPSN patients.
The study population did not include diabetes patients without
neuropathy, or an unselected diabetes cohort. Several correlations
between visceral, cutaneous and cardiac autonomic neuropathies
were detected, indicating a co-development of these complications.
Still, the chronological order of the neurological deficits remains to be
unraveled. Finally, not all participants were able to complete the
entire experimental protocol, yielding a somewhat weaker statistical
power than originally anticipated. On this basis, borderline significant
results should be interpreted with caution.
The muscle and bone pressure protocols have been validated and
applied in several previous studies (Andresen et al., 2013; Staahl et al.,
2007). Muscle algometry is predominantly a measure of deep muscle
strain sensitivity, and to a lesser degree superficial structures,
whereas bone algometry predominantly stimulates the periosteal
mechanosensitive nociceptors.Autonomic nervous system patency has traditionally been inves-
tigated based on the methods proposed by Ewing & Clarke (1986). In
this study we investigated two of the original Ewing parameters (i.e.
heart rate response to standing up and to deep respiration), and in
addition the HRV at 5-min rest. Although a reference database with
normal values exists, our patients had an age distributionwith several
elderly participants, emphasizing the need for a matched control
group as HRV decreases in the elderly (Phillips & Powley, 2007).
The investigation of visceral sensations is complicated due to the
relative inaccessibility of gut organs, the diffuse nature of visceral pain
and the complex organization of visceral afferents running in parallel
with the autonomic nerves. Previous studies have investigated
esophageal sensitivity in diabetic autonomic neuropathy, however
an esophageal probe can be hard to tolerate, in particular in these
patients who frequently suffer from nausea and reflux (Frokjaer et al.,
2007). Our research group has substantial experience when it comes
to both esophageal and rectosigmoid sensory stimulations as a proxy
of visceral sensitivity, and the multimodal probe has been employed
in several previous studies on neuropathic conditions as well as in
healthy individuals (Brock, Arendt-Nielsen, Wilder-Smith, & Drewes,
2009). The probe design allows the investigation of three modalities
in one session, thus approaching a more complete and physiologically
meaningful examination at the same time addressing the limitations
of the individual test modalities. Thermal sensations are thought to be
predominantly mucosal whereas mechanical stimulation mainly
376 E. Søfteland et al. / Journal of Diabetes and Its Complications 28 (2014) 370–377activates a stretch sensation of the muscle layer. Electrical stimulation
bypasses all the sensory receptors, directly activating the nerves
(Burgell & Scott, 2012).
Finally, a strong central nervous system component with func-
tional and neuroplastic changes has been shown in both somatic and
visceral diabetic neuropathies, the influence of which this study did
not aim to investigate (Brock et al., 2012; Frokjaer et al., 2009;
Selvarajah, Wilkinson, Davies, Gandhi, & Tesfaye, 2011).
5. Clinical considerations
This study revealed an association between GI complaints and
reduced HRV as well as a positive correlation between GI complaints
and rectal hyposensitivity. By contrast, functional disorders such as
irritable bowel syndrome are characterized by visceral hypersensitiv-
ity (Kanazawa, Hongo, & Fukudo, 2011). In addition to disease-related
causes, other mechanisms have been proposed to explain the high
prevalence of GI symptoms in DM. These include psychological stress
of a chronic disorder such as DM (de et al., 2012; Talley et al., 2001),
and side effects of common diabetes medications i.e. metformin and
glucagon-like peptide 1-analogues (Aroda & Ratner, 2011; Icks,
Haastert, Rathmann, &Wareham, 2002). The present findings indicate
that visceral and/or autonomic neuropathies could be central
components in the pathogenesis of visceral symptoms and pain in
this patient population. Studies in streptozotocin-induced diabetic
rats also indicate that the function of rectal visceral afferents
deteriorates at an early stage of DM (Beyak, Bulmer, Sellers, &
Grundy, 2009), and enteric neurodegeneration appears early in such
models (Chandrasekharan & Srinivasan, 2007).
Interestingly, diabetes patients had normal pain sensitivity to
muscle and bone pressure stimulation, in spite of a clear visceral and
skin hyposensitivity. Thus, these deep pain perception pathways seem
to be less affected in DSPN, although little is known about the
epidemiology of myalgia and ostealgia in DM. Similar apparent
discrepancies are found in patients with chronic painful pancreatitis, a
condition with a marked neuropathic component. These patients
show visceral and skin hyposensitivity, but normal muscle pain
pressure sensitivity (Dimcevski et al., 2006; Dimcevski et al., 2007).
6. Therapeutical considerations
The results indicate that once the patient has developed
sensorimotor neuropathy, there are already coexisting diffuse
neuropathic complications in the cardiac and visceral autonomic
nervous systems, associated with GI complaints and reduced HRV.
This finding is novel, but not surprising, as small fiber neuropathy
has been found to precede that of larger myelinated nerve fiber
damage in several studies (Loseth, Stalberg, Jorde, & Mellgren, 2008;
Sumner, Sheth, Griffin, Cornblath, & Polydefkis, 2003). Early
detection using HRV or other sensitive small fiber tests followed
by therapeutic interventions should be attempted in larger, clinical
studies. Thus far, neuroprotective interventions apart from glycemic
control have been unsuccessful. However, newly developed c-peptide
analogues, and the recently implemented incretin-based therapies
show theoretical potential in this respect (Holst, Burcelin, &
Nathanson, 2011; Wahren, Kallas, & Sima, 2012). No human
randomized controlled trial with small fiber neuropathy as primary
end-point has yet been published.
7. Conclusion
In diabetes patients with sensorimotor neuropathy there are
concurrent rectal hyposensitivity and reduced heart rate variability,
indicating an affection of both visceral and cardiac autonomic
nerves. The degree of rectal hyposensitivity is associated to reduced
HRV, gastrointestinal symptoms and reduced quality of life, thusindicating a clinical significance of the results. Clinicians should
consider autonomic complications in patients presenting with
peripheral sensorimotor neuropathy. Early detection of small fiber
neuropathy and continued research into neuroprotective interven-
tions are needed.Acknowledgments
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